ClassID:

92543

C07C215/60 - CPC Classification

Classification description:

Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Recent Application in this class:
#1
20250161500
2025-05-22

LIGANDS FOR IMAGING CARDIAC INNERVATION

#2
20250051262
2025-02-13

CRYSTALLINE EPINEPHRINE MALONATE SALT

#3
20230086578
2023-03-23

Crystalline epinephrine malonate salt

#4
20220402861
2022-12-22

A Crystalline form of (R)-terbutaline Hydrochloride

#5
20220288243
2022-09-15

LIGANDS FOR IMAGING CARDIAC INNERVATION

#6
20210214301
2021-07-15

Crystalline epinephrine malonate salt

#7
20210107853
2021-04-15

Synthesis of mono-chlorinated acetophenone

#8
20210061757
2021-03-04

PROCESS FOR THE SYNTHESIS OF OPTICALLY ACTIVE BETA-AMINO ALCOHOLS

#9
20200165190
2020-05-28

Amorphous form of vilanterol trifenatate and processes for the preparation thereof

#10
20200148626
2020-05-14

Crystalline forms of vilanterol trifenatate and processes for their preparation

#11
20200031758
2020-01-30

Crystalline epinephrine malonate salt

#12
20190367443
2019-12-05

Process for preparation of isoproterenol hydrochloride

#13
20190337889
2019-11-07

COMPOSITIONS AND METHODS OF REGULATING CANCER RELATED DISORDERS AND DISEASES

#14
20190248732
2019-08-15

Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

#15
20190119196
2019-04-25

COMPOUNDS FOR THE TREATMENT OF HYPERGLYCAEMIA

#16
20180339070
2018-11-29

Ligands for imaging cardiac innervation

#17
20180297966
2018-10-18

COMPOUNDS, COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME

#18
20180222845
2018-08-09

LEVALBUTEROL SALT

#19
20180141894
2018-05-24

Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

#20
20170158609
2017-06-08

Method for synthesizing catecholamines by using plasma polymerization

#21
20170081276
2017-03-23

Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

#22
20160368858
2016-12-22

LEVALBUTEROL SALT

#23
20160009636
2016-01-14

Preparation of ()-fenoterol and ()-or ()-fenoterol analogues and their use in treating congestive heart failure

#24
20150071969
2015-03-12

LEVALBUTEROL SALT

#25
20140329907
2014-11-06

Catecholamine derivatives for obesity and neurological disorders

#26
20140187645
2014-07-03

Preparation of ()-fenoterol and ()-or ()-fenoterol analogues and their use in treating congestive heart failure

#27
20140030189
2014-01-30

Ligands for imaging cardiac innervation

#28
20130236515
2013-09-12

Levalbuterol salt

#29
20130123539
2013-05-16

Methods for preparing ritodrine hydrochloride

#30
20130028845
2013-01-31

LEVALBUTEROL SALT

#31
20120157543
2012-06-21

Preparation of ()-fenoterol and ()-or ()-fenoterol analogues and their use in treating congestive heart failure

#32
20120022086
2012-01-26

CATECHOLAMINE DERIVATIVES FOR OBESITY AND NEUROLOGICAL DISORDERS

#33
20120015895
2012-01-19

Use of RR/SR-ractopamine

#34
20110118307
2011-05-19

Compositions and methods for the treatment of infectious diseases

#35
20100272654
2010-10-28

LEVALBUTEROL SALT

#36
20100222257
2010-09-02

SUBSTITUTED PHENETHYLAMINES

#37
20100221182
2010-09-02

Ligands for imaging cardiac innervation

#38
20100204516
2010-08-12

Process for the preparation of optically pure R (−) salbutamol and its pharmaceutically acceptable salts

#39
20100184865
2010-07-22

Use of RR/SR-ractopamine

#40
20100168245
2010-07-01

PREPARATION OF (R,R)-FENOTEROL AND (R,R)-OR (R,S)-FENOTEROL ANALOGUES AND THEIR USE IN TREATING CONGESTIVE HEART FAILURE

#41
20090263333
2009-10-22

Pharmaceutical compounds and compositions

#42
20090143480
2009-06-04

Use of RR/SR-ractopamine

#43
20080300316
2008-12-04

Substituted phenethylamines

#44
20080269344
2008-10-30

Beta2-Adrenergic Receptor Agonists

#45
20080146554
2008-06-19

Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament

#46
20080132579
2008-06-05

Preparation of levalbuterol hydrochloride

#47
20080119564
2008-05-22

Levalbuterol salt

#48
20080058383
2008-03-06

Androgen Receptor Modulators

#49
20080021244
2008-01-24

Levalbuterol hydrochloride Polymorph A

#50
20070225329
2007-09-27

Aryl aniline βadrenergic receptor agonists

#51
20070179179
2007-08-02

β2-adrenergic receptor agonists

#52
20070088174
2007-04-19

Synthesis of phenoxyacetic acid derivatives

#53
20070060656
2007-03-15

Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof

#54
20070041911
2007-02-22

HFC SOLUTION FORMULATIONS CONTAINING SALBUTAMOL HYDROCHLORIDE OR SALBUTAMOL CITRATE

#55
20060183918
2006-08-17

β2-adrenergic receptor agonists

#56
20060178410
2006-08-10

Aryl aniline β2 adrenergic receptor agonists

#57
20060122431
2006-06-08

Process for preparing (R)-salbutamol

#58
20060020041
2006-01-26

Anti tubercular drug: compositions and methods

#59
20050272821
2005-12-08

Levalbuterol hydrochloride Polymorph A

#60
20050267216
2005-12-01

Levalbuterol hydrochloride polymorph B

#61
20050261368
2005-11-24

Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof

#62
20050261338
2005-11-24

β2-adrenergic receptor agonists

#63
20050261286
2005-11-24

Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament

#64
20050250944
2005-11-10

Synthesis and uses of synephrine derivatives

#65
20050209486
2005-09-22

Phenol derivatives and method of use thereof

#66
20050209275
2005-09-22

β2-adrenergic receptor agonists

#67
20050192316
2005-09-01

Aryl aniline βadrenergic receptor agonists

#68
20050148801
2005-07-07

Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof

#69
20050009926
2005-01-13

Process for preparing (R)-salbutamol